INCRUSE ELLIPTA Trademark

Trademark Overview

On Saturday, March 29, 2014, a trademark application was filed for INCRUSE ELLIPTA with the United States Patent and Trademark Office. The USPTO has given the INCRUSE ELLIPTA trademark a serial number of 86236331. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, June 27, 2023. This trademark is owned by Glaxo Group Limited. The INCRUSE ELLIPTA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations and substances for the treatment of respiratory diseases and conditions
incruse ellipta

General Information

Serial Number86236331
Word MarkINCRUSE ELLIPTA
Filing DateSaturday, March 29, 2014
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, June 27, 2023
Registration Number5186819
Registration DateTuesday, April 18, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 29, 2014

Trademark Statements

Goods and Servicespharmaceutical preparations and substances for the treatment of respiratory diseases and conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 11, 2014
Primary Code005
First Use Anywhere DateMonday, January 26, 2015
First Use In Commerce DateMonday, January 26, 2015

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Wednesday, July 5, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 5, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 5, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 5, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 5, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 27, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, June 27, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, June 27, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, January 4, 2023TEAS SECTION 8 & 15 RECEIVED
Tuesday, November 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 8, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, April 18, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, April 18, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, March 14, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, March 13, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, March 10, 2017STATEMENT OF USE PROCESSING COMPLETE
Thursday, February 23, 2017USE AMENDMENT FILED
Thursday, February 23, 2017TEAS STATEMENT OF USE RECEIVED
Saturday, October 22, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 21, 2016SOU EXTENSION 4 GRANTED
Friday, September 23, 2016SOU EXTENSION 4 FILED
Friday, September 23, 2016TEAS EXTENSION RECEIVED
Wednesday, March 30, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 29, 2016SOU EXTENSION 3 GRANTED
Wednesday, March 23, 2016SOU EXTENSION 3 FILED
Wednesday, March 23, 2016TEAS EXTENSION RECEIVED
Wednesday, December 16, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 15, 2015SOU EXTENSION 2 GRANTED
Wednesday, September 23, 2015SOU EXTENSION 2 FILED
Friday, December 4, 2015NOTICE OF REVIVAL - E-MAILED
Friday, December 4, 2015EXTENSION RECEIVED WITH TEAS PETITION
Friday, December 4, 2015PETITION TO REVIVE-GRANTED
Friday, December 4, 2015TEAS PETITION TO REVIVE RECEIVED
Monday, October 26, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 26, 2015ABANDONMENT - NO USE STATEMENT FILED
Wednesday, May 20, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 19, 2015SOU EXTENSION 1 GRANTED
Monday, March 23, 2015SOU EXTENSION 1 FILED
Wednesday, May 13, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 25, 2015NOTICE OF REVIVAL - E-MAILED
Wednesday, March 25, 2015EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, March 25, 2015PETITION TO REVIVE-GRANTED
Wednesday, March 25, 2015TEAS PETITION TO REVIVE RECEIVED
Tuesday, September 23, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 29, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 29, 2014PUBLISHED FOR OPPOSITION
Wednesday, July 9, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 25, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, June 23, 2014ASSIGNED TO LIE
Thursday, June 5, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 5, 2014EXAMINER'S AMENDMENT ENTERED
Thursday, June 5, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, June 5, 2014EXAMINERS AMENDMENT E-MAILED
Thursday, June 5, 2014EXAMINERS AMENDMENT -WRITTEN
Tuesday, June 3, 2014EXAMINER'S AMENDMENT ENTERED
Tuesday, June 3, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, June 3, 2014EXAMINERS AMENDMENT E-MAILED
Tuesday, June 3, 2014EXAMINERS AMENDMENT -WRITTEN
Monday, June 2, 2014ASSIGNED TO EXAMINER
Friday, April 11, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 2, 2014NEW APPLICATION ENTERED

Related Keywords

ellipta incruse diseases conditions respiratory treatment preparations substances pharmaceutical